Ignite Creation Date:
2024-05-05 @ 11:25 AM
Last Modification Date:
2024-10-26 @ 9:07 AM
Study NCT ID:
NCT00031395
Status:
COMPLETED
Last Update Posted:
2009-05-21
First Post:
2002-03-04
Brief Title:
Clonidine in Attention Deficit Hyperactivity Disorder ADHD in Children
Sponsor:
University of Cincinnati
Organization:
University of Cincinnati
Study Overview
Official Title:
Clonidine in Attention Deficit Hyperactivity Disorder ADHD Treatment CAT
Status:
COMPLETED
Status Verified Date:
2009-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to determine the safety and efficacy of clonidine alone or in combination with methylphenidate for children 7-12 years of age with attention-deficit hyperactivity disorder
Detailed Description:
This trial will compare the benefits and side effects of two medications-clonidine and methylphenidate MPH-used alone or in combination to treat ADHD in children MPH is FDA-approved for the treatment of ADHD symptoms in children and clonidine is FDA-approved for the treatment of hypertension in adults Stimulant medications such as MPH are known to be safe and effective for the treatment of many ADHD symptoms Such medicines however do not cure the condition or improve all of the symptoms of ADHD and the long-term effectiveness of these medications is not well-known In this study the participants will be randomly selected to receive one of four treatments 1 clonidine 2 MPH 3 clonidine and MPH or 4 a placebo which is not an active medication but a substance that is thought to have no biological effect The time participation in the study is 16 weeks
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None